Poly Medicure Board of Directors
Get the latest insights into the leadership at Poly Medicure. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Devendra Mehta | Chairman |
| Jugal Kishore Baid | Non Independent & Non Executive Director |
| Vishal Baid | Executive Director |
| Ambrish Mithal | Non Executive Independent Director |
| Himanshu Baid | Managing Director |
| Rishi Baid | Joint Managing Director |
| Vishal Gupta | Non Executive Independent Director |
| Vimal Bhandari | Non Executive Independent Director |
| Alessandro Balboni | Non Independent & Non Executive Director |
| Amit Khosla | Non Executive Independent Director |
| Sonal Mattoo | Non Executive Independent Director |
| Pankaj Kumar Gupta | Whole Time Director |
| Avinash Chandra | Company Secretary |
| Ravi Prakash | Deputy Company Secretary |
Poly Medicure FAQs
The board at Poly Medicure consists of experienced professionals, including Devendra Mehta, Jugal Kishore Baid, and others, overseeing the company’s strategic and corporate governance.
Directors at Poly Medicure are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Devendra Mehta is the current chairman at Poly Medicure.
Executive directors at Poly Medicure are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Poly Medicure adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Poly Medicure, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
